This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Zhao L, Zhang Z, Kolm P, Jasper S, Lewis C, Klein A, Weintraub W, ACUTE II Investigators.Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from assessment of cardioversion using transesophageal echocardiography [ACUTE] II randomized multicenter study). American Journal of Cardiology 101: 338-342, No. 3, Feb 2008
Rights and permissions
About this article
Cite this article
Enoxaparin cost saving in AF. Pharmacoecon. Outcomes News 549, 6 (2008). https://doi.org/10.2165/00151234-200805490-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805490-00017